POLLY KAUFMAN: Open Payments
NPI 1811127962 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$411 in 21 payments from 8 companies in 2025. Trend: 2023 $336 · 2024 $159 · 2025 $411
Food & beverage: $411
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $245 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $41 |
| Inspire Medical Systems, Inc. | 1 | $37 |
| Organon LLC | 1 | $25 |
| Lilly USA, LLC | 1 | $17 |
| Greer Laboratories, Inc. | 1 | $16 |
| Genentech USA, Inc. | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
Products named: DUPIXENT, NEFFY, INSPIRE, AYVAKIT, EBGLYSS, Palforzia, Xolair.
Industry payments across LA — which companies pay providers there.
